New York Presbyterian University Hospital of Columbia and Cornell
Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma
St. Luke's International Hospital
Cutting-Edge Targeted Drug For Cholangiocarcinoma Significantly Extends Patients' Lives!
Perkinelmer Launches Industry-First Cell Analysis Solution
The "hand speed" is extremely fast, and scientists create a DNA robot arm that can move at a high speed
